Ci Private Wealth, LLC Crispr Therapeutics Ag Transaction History
Ci Private Wealth, LLC
- $65.6 Billion
- Q4 2024
A detailed history of Ci Private Wealth, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Ci Private Wealth, LLC holds 8,827 shares of CRSP stock, worth $349,725. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,827
Previous 9,192
3.97%
Holding current value
$349,725
Previous $431,000
19.49%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CRSP
# of Institutions
493Shares Held
59.4MCall Options Held
1.09MPut Options Held
1.9M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$356 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA7.93MShares$314 Million0.07% of portfolio
-
State Street Corp Boston, MA2.99MShares$119 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$110 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$109 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.09B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....